Science A Personalised Vaccine Enters Early Testing in Ovarian Cancer by Lachlan Ross October 16, 2026 by Lachlan Ross October 16, 2026 A Personalised Vaccine Enters Early Testing in Ovarian Cancer. A phase 1 Nature Medicine trial finds NeoVax with nivolumab feasible with acceptable. 0 FacebookTwitterPinterestEmail
